S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.87 (+1.07%)
AAPL   146.60 (+1.22%)
MSFT   307.25 (+1.00%)
FB   335.30 (+3.25%)
GOOGL   2,854.69 (+0.97%)
TSLA   870.65 (+3.28%)
AMZN   3,446.66 (+1.10%)
NVDA   222.22 (+1.65%)
BABA   166.98 (-0.61%)
NIO   39.63 (+5.09%)
CGC   13.21 (-1.05%)
GE   104.11 (-0.29%)
MU   67.26 (-0.62%)
AMD   116.44 (+3.85%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.13 (-3.02%)
PFE   41.34 (-0.36%)
BA   217.05 (+0.00%)
AMC   43.04 (+5.65%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.87 (+1.07%)
AAPL   146.60 (+1.22%)
MSFT   307.25 (+1.00%)
FB   335.30 (+3.25%)
GOOGL   2,854.69 (+0.97%)
TSLA   870.65 (+3.28%)
AMZN   3,446.66 (+1.10%)
NVDA   222.22 (+1.65%)
BABA   166.98 (-0.61%)
NIO   39.63 (+5.09%)
CGC   13.21 (-1.05%)
GE   104.11 (-0.29%)
MU   67.26 (-0.62%)
AMD   116.44 (+3.85%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.13 (-3.02%)
PFE   41.34 (-0.36%)
BA   217.05 (+0.00%)
AMC   43.04 (+5.65%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.87 (+1.07%)
AAPL   146.60 (+1.22%)
MSFT   307.25 (+1.00%)
FB   335.30 (+3.25%)
GOOGL   2,854.69 (+0.97%)
TSLA   870.65 (+3.28%)
AMZN   3,446.66 (+1.10%)
NVDA   222.22 (+1.65%)
BABA   166.98 (-0.61%)
NIO   39.63 (+5.09%)
CGC   13.21 (-1.05%)
GE   104.11 (-0.29%)
MU   67.26 (-0.62%)
AMD   116.44 (+3.85%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.13 (-3.02%)
PFE   41.34 (-0.36%)
BA   217.05 (+0.00%)
AMC   43.04 (+5.65%)
S&P 500   4,486.46 (+0.34%)
DOW   35,258.61 (-0.10%)
QQQ   372.87 (+1.07%)
AAPL   146.60 (+1.22%)
MSFT   307.25 (+1.00%)
FB   335.30 (+3.25%)
GOOGL   2,854.69 (+0.97%)
TSLA   870.65 (+3.28%)
AMZN   3,446.66 (+1.10%)
NVDA   222.22 (+1.65%)
BABA   166.98 (-0.61%)
NIO   39.63 (+5.09%)
CGC   13.21 (-1.05%)
GE   104.11 (-0.29%)
MU   67.26 (-0.62%)
AMD   116.44 (+3.85%)
T   25.33 (-1.44%)
F   15.56 (-0.89%)
ACB   6.92 (-1.56%)
DIS   171.13 (-3.02%)
PFE   41.34 (-0.36%)
BA   217.05 (+0.00%)
AMC   43.04 (+5.65%)

Compare Stocks

Date Range: 

 AbiomedTeleflexNovoCureInsuletPenumbra
SymbolNASDAQ:ABMDNYSE:TFXNASDAQ:NVCRNASDAQ:PODDNYSE:PEN
Price Information
Current Price$350.89$359.97$110.09$291.93$266.00
50-Day Moving Average$345.95$379.83$128.36$292.90$268.93
52-Week Low$242.73$312.33$108.31$214.93$163.49
52-Week High$387.40$449.38$232.76$309.99$320.00
MarketRank™
Overall Score2.02.82.12.12.4
Analysis Score1.14.53.11.32.5
Community Score4.54.14.54.75.0
Dividend Score0.01.70.00.00.0
Ownership Score2.52.52.52.52.5
Earnings & Valuation Score1.91.30.61.91.9
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyBuy
Consensus Price Target$363.75$455.80$186.14$283.50$324.86
% Upside from Price Target3.66% upside26.62% upside69.08% upside-2.89% downside22.13% upside
Trade Information
Market Cap$15.92 billion$16.85 billion$11.41 billion$20.11 billion$9.73 billion
Beta1.311.191.10.670.28
Average Volume261,435249,672756,109442,942290,513
Sales & Book Value
Annual Revenue$847.52 million$2.54 billion$494.37 million$904.40 million$560.41 million
Price / Sales18.796.6423.0822.2317.36
Cashflow$5.36 per share$15.28 per share$0.27 per share$0.93 per share$0.50 per share
Price / Cash65.4523.56401.56314.18528.80
Book Value$29.40 per share$71.65 per share$4.68 per share$9.16 per share$17.56 per share
Price / Book11.945.0223.5231.8715.15
Profitability
Net Income$225.52 million$335.32 million$19.81 million$6.80 million$-15.70 million
EPS$4.94$10.67$0.18$0.10$0.11
Trailing P/E Ratio104.4348.58N/AN/A618.60
Forward P/E Ratio66.2124.671,834.83202.73160.24
P/E Growth5.771.91N/AN/A13.67
Net Margins16.51%13.06%-0.84%-3.06%2.37%
Return on Equity (ROE)16.35%17.29%-1.18%0.21%5.52%
Return on Assets (ROA)14.55%8.33%-0.50%0.06%4.21%
Dividend
Annual PayoutN/A$1.36N/AN/AN/A
Dividend YieldN/A0.38%N/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A12.75%N/AN/AN/A
Years of Consecutive Dividend GrowthN/A1 YearsN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.64%1.41%2.69%0.04%
Current Ratio6.45%2.73%9.00%5.87%6.04%
Quick Ratio5.71%1.80%8.77%4.95%3.68%
Ownership Information
Institutional Ownership Percentage90.37%91.38%74.09%99.99%80.61%
Insider Ownership Percentage3.00%1.34%5.07%1.00%7.50%
Miscellaneous
Employees1,72514,0001,0231,9003,300
Shares Outstanding45.38 million46.80 million103.65 million68.87 million36.58 million
Next Earnings Date10/28/2021 (Confirmed)10/28/2021 (Confirmed)10/28/2021 (Confirmed)11/4/2021 (Confirmed)11/3/2021 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Hedge Funds Are Piling Into Penumbra Inc (PEN) - Yahoo FinanceHedge Funds Are Piling Into Penumbra Inc (PEN) - Yahoo Finance
finance.yahoo.com - October 18 at 7:06 AM
Hedge Funds Are Piling Into Penumbra Inc (PEN)Hedge Funds Are Piling Into Penumbra Inc (PEN)
finance.yahoo.com - October 18 at 7:06 AM
Penumbra (NYSE:PEN) vs. NuVasive (NASDAQ:NUVA) Head to Head ReviewPenumbra (NYSE:PEN) vs. NuVasive (NASDAQ:NUVA) Head to Head Review
americanbankingnews.com - October 17 at 5:16 PM
Down in the woods with our top truffle dealer … and his dog - The GuardianDown in the woods with our top truffle dealer … and his dog - The Guardian
theguardian.com - October 17 at 10:28 AM
Penumbra - Consensus Indicates Potential 21.4% Upside - DirectorsTalk InterviewsPenumbra - Consensus Indicates Potential 21.4% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - October 15 at 10:06 AM
Notable Penumbra Insider Trades $3.8M In Company Stock - BenzingaNotable Penumbra Insider Trades $3.8M In Company Stock - Benzinga
benzinga.com - October 14 at 2:18 PM
Neurovascular Embolization Device Market Size, Forecast, and Top Firms – Medtronic, Stryker, Terumo, Johnson & Johnson Services, Penumbra – Otterbein 360 - Otterbein 360Neurovascular Embolization Device Market Size, Forecast, and Top Firms – Medtronic, Stryker, Terumo, Johnson & Johnson Services, Penumbra – Otterbein 360 - Otterbein 360
otterbein360.com - October 13 at 7:33 PM
Improving response for people at risk of suicide - Scottish Government NewsImproving response for people at risk of suicide - Scottish Government News
gov.scot - October 13 at 8:43 AM
Disclaimer in Prosecution cannot be Recaptured in Litigation - Patently-ODisclaimer in Prosecution cannot be Recaptured in Litigation - Patently-O
patentlyo.com - October 12 at 1:02 PM
Brainomix LTD - Stroke Imaging Solutions using AI-powered imaging - Open Access GovernmentBrainomix LTD - Stroke Imaging Solutions using AI-powered imaging - Open Access Government
openaccessgovernment.org - October 11 at 8:38 PM
Embolotherapy Market May See a Big Move by Tackling the Hurdles, Key Players – Penumbra,Cook Medical,Abbott - Global Banking And Finance ReviewEmbolotherapy Market May See a Big Move by Tackling the Hurdles, Key Players – Penumbra,Cook Medical,Abbott - Global Banking And Finance Review
globalbankingandfinance.com - October 11 at 3:31 PM
Microcatheter Market Size, Growth and Key Manufacturers – Cook Group Incorporated, Medtronic Plc, Merit Medical Systems Stryker Corporation, Terumo Corporation, Penumbra Inc., Boston Scientific Corporation – The Manomet Current - The Manomet CurrentMicrocatheter Market Size, Growth and Key Manufacturers – Cook Group Incorporated, Medtronic Plc, Merit Medical Systems Stryker Corporation, Terumo Corporation, Penumbra Inc., Boston Scientific Corporation – The Manomet Current - The Manomet Current
manometcurrent.com - October 11 at 10:30 AM
The current U.S. Supreme Court has stated its above politics. That might not matter - Herald-Mail MediaThe current U.S. Supreme Court has stated it's above politics. That might not matter - Herald-Mail Media
heraldmailmedia.com - October 10 at 9:06 AM
Theater leader Faye M. Price named this years McKnight Distinguished Artist - Minnesota Public Radio NewsTheater leader Faye M. Price named this year's McKnight Distinguished Artist - Minnesota Public Radio News
mprnews.org - October 9 at 12:17 AM
Submissions Now Open for Penumbras 2021 Fall Call | Arts Entertainment | csusignal.com - The SignalSubmissions Now Open for Penumbra's 2021 Fall Call | Arts Entertainment | csusignal.com - The Signal
csusignal.com - October 8 at 7:16 PM
Penumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021 - WBRCPenumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021 - WBRC
wbrc.com - October 8 at 7:16 PM
Global Neurovascular Devices for Ischemic Stroke Market 2020-2025 Featuring Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and - ACROFAN USAGlobal Neurovascular Devices for Ischemic Stroke Market 2020-2025 Featuring Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and - ACROFAN USA
us.acrofan.com - October 8 at 2:16 PM
Neurovascular Embolization Device Market Analysis and Forecast (2021-2029) | Medtronic, Stryker, Terumo, Johnson & Johnson Services, Penumbra, Balt Extrusion – Amite Tangy Digest - Amite Tangy DigestNeurovascular Embolization Device Market Analysis and Forecast (2021-2029) | Medtronic, Stryker, Terumo, Johnson & Johnson Services, Penumbra, Balt Extrusion – Amite Tangy Digest - Amite Tangy Digest
amitetoday.com - October 8 at 9:15 AM
Global Neurovascular Devices for Ischemic Stroke Market 2020-2025 Featuring Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and More - ResearchAndMarkets.com - Business WireGlobal Neurovascular Devices for Ischemic Stroke Market 2020-2025 Featuring Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and More - ResearchAndMarkets.com - Business Wire
businesswire.com - October 8 at 9:15 AM
PENUMBRA INC : Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities (form 8-K) - marketscreener.comPENUMBRA INC : Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities (form 8-K) - marketscreener.com
marketscreener.com - October 7 at 6:00 PM
Forth Road Bridge charity challenge for Dunfermline mental health workers - Dunfermline PressForth Road Bridge charity challenge for Dunfermline mental health workers - Dunfermline Press
dunfermlinepress.com - October 7 at 1:00 PM
McKnight names Faye Price as its 2021 Distinguished Artist - Minneapolis Star TribuneMcKnight names Faye Price as its 2021 Distinguished Artist - Minneapolis Star Tribune
startribune.com - October 7 at 1:00 PM
McKnight Foundation names Faye M. Price its 2021 Distinguished Artist - TwinCities.com-Pioneer PressMcKnight Foundation names Faye M. Price its 2021 Distinguished Artist - TwinCities.com-Pioneer Press
twincities.com - October 7 at 7:59 AM
Penumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021 - WAGMPenumbra, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 3, 2021 - WAGM
wagmtv.com - October 7 at 7:59 AM
St. Pauls Penumbra Theatre Announces 2021-22 Season - Mpls.St.Paul MagazineSt. Paul's Penumbra Theatre Announces 2021-22 Season - Mpls.St.Paul Magazine
mspmag.com - October 7 at 7:59 AM
DateCompanyBrokerageAction
9/16/2021PenumbraTruist Securities
Initiated Coverage
9/15/2021PenumbraTruist
Initiated Coverage
9/10/2021TeleflexJefferies Financial Group
Initiated Coverage
9/7/2021TeleflexRaymond James
Initiated Coverage
8/10/2021PenumbraCitigroup
Boost Price Target
8/10/2021PenumbraBTIG Research
Boost Price Target
8/6/2021AbiomedSVB Leerink
Boost Price Target
8/6/2021AbiomedDeutsche Bank Aktiengesellschaft
Boost Price Target
8/6/2021InsuletSVB Leerink
Lower Price Target
8/6/2021InsuletCanaccord Genuity
Boost Price Target
8/6/2021InsuletCitigroup
Boost Price Target
8/2/2021TeleflexKeyCorp
Lower Price Target
7/30/2021TeleflexJMP Securities
Reiterated Rating
7/30/2021TeleflexSVB Leerink
Boost Price Target
7/30/2021NovoCureWells Fargo & Company
Lower Price Target
7/30/2021NovoCureMizuho
Lower Price Target
7/29/2021NovoCurePiper Sandler
Reiterated Rating
7/21/2021InsuletCowen
Boost Price Target
7/20/2021AbiomedSVB Leerink
Lower Price Target
7/20/2021InsuletSVB Leerink
Boost Price Target
7/19/2021TeleflexSVB Leerink
Downgrade
7/9/2021TeleflexNeedham & Company LLC
Initiated Coverage
7/9/2021NovoCurePiper Sandler
Boost Price Target
7/1/2021NovoCureNorthland Securities
Initiated Coverage
7/1/2021NovoCureMizuho
Downgrade
6/18/2021AbiomedDeutsche Bank Aktiengesellschaft
Initiated Coverage
6/8/2021PenumbraWells Fargo & Company
Reiterated Rating
6/6/2021AbiomedSVB Leerink
Reiterated Rating
6/4/2021PenumbraBTIG Research
Upgrade
6/2/2021TeleflexJefferies Financial Group
Reiterated Rating
5/24/2021InsuletBarclays
Initiated Coverage
5/23/2021TeleflexSVB Leerink
Reiterated Rating
5/7/2021InsuletRaymond James
Lower Price Target
5/7/2021InsuletSVB Leerink
Lower Price Target
5/7/2021InsuletPiper Sandler
Lower Price Target
5/7/2021InsuletBTIG Research
Reiterated Rating
5/5/2021PenumbraCitigroup
Boost Price Target
5/5/2021PenumbraWells Fargo & Company
Boost Price Target
5/5/2021PenumbraCanaccord Genuity
Boost Price Target
4/30/2021TeleflexMorgan Stanley
Boost Price Target
4/30/2021TeleflexSVB Leerink
Boost Price Target
4/20/2021NovoCureWedbush
Reiterated Rating
4/19/2021NovoCureTruist
Boost Price Target
4/19/2021NovoCureTruist Securities
Boost Price Target
4/14/2021NovoCureNorthland Securities
Boost Price Target
4/14/2021NovoCureWedbush
Downgrade
4/14/2021NovoCureMizuho
Boost Price Target
4/13/2021NovoCureWells Fargo & Company
Boost Price Target
4/1/2021InsuletSVB Leerink
Upgrade
3/19/2021InsuletCanaccord Genuity
Upgrade
3/12/2021TeleflexRaymond James
Boost Price Target
3/2/2021InsuletSVB Leerink
Boost Price Target
3/1/2021NovoCureMizuho
Boost Price Target
2/26/2021TeleflexRaymond James
Boost Price Target
2/25/2021TeleflexPiper Sandler
Reiterated Rating
2/25/2021InsuletOppenheimer
Boost Price Target
2/24/2021InsuletSVB Leerink
Reiterated Rating
2/24/2021InsuletRaymond James
Boost Price Target
2/24/2021PenumbraCitigroup
Boost Price Target
2/24/2021PenumbraCanaccord Genuity
Boost Price Target
2/24/2021PenumbraWells Fargo & Company
Boost Price Target
2/1/2021InsuletBTIG Research
Reiterated Rating
1/29/2021AbiomedSVB Leerink
Boost Price Target
1/29/2021AbiomedMorgan Stanley
Boost Price Target
1/29/2021NovoCureTruist
Boost Price Target
1/29/2021InsuletPiper Sandler
Downgrade
1/28/2021AbiomedPiper Sandler
Boost Price Target
1/27/2021TeleflexJMP Securities
Boost Price Target
1/25/2021NovoCurePiper Sandler
Boost Price Target
1/15/2021InsuletWells Fargo & Company
Reiterated Rating
1/12/2021NovoCureWedbush
Boost Price Target
1/11/2021TeleflexWells Fargo & Company
Boost Price Target
1/8/2021TeleflexKeyCorp
Boost Price Target
1/6/2021TeleflexNeedham & Company LLC
Boost Price Target
12/21/2020AbiomedSVB Leerink
Boost Price Target
12/16/2020InsuletSmith Barney Citigroup
Downgrade
12/16/2020PenumbraWells Fargo & Company
Lower Price Target
12/16/2020PenumbraCanaccord Genuity
Lower Price Target
12/16/2020PenumbraBTIG Research
Downgrade
12/15/2020AbiomedMorgan Stanley
Boost Price Target
12/15/2020TeleflexMorgan Stanley
Boost Price Target
12/15/2020TeleflexUBS Group
Boost Price Target
12/15/2020TeleflexSVB Leerink
Boost Price Target
12/15/2020InsuletMorgan Stanley
Boost Price Target
12/3/2020TeleflexRaymond James
Boost Price Target
11/5/2020InsuletCanaccord Genuity
Boost Price Target
11/5/2020InsuletUBS Group
Boost Price Target
11/5/2020InsuletWells Fargo & Company
Boost Price Target
11/5/2020InsuletRaymond James
Boost Price Target
11/2/2020TeleflexKeyCorp
Upgrade
10/30/2020TeleflexPiper Sandler
Lower Price Target
10/30/2020TeleflexMorgan Stanley
Lower Price Target
10/30/2020NovoCureMizuho
Boost Price Target
10/29/2020NovoCurePiper Sandler
Boost Price Target
10/29/2020PenumbraSmith Barney Citigroup
Boost Price Target
10/29/2020PenumbraWells Fargo & Company
Boost Price Target
10/29/2020PenumbraCanaccord Genuity
Boost Price Target
10/29/2020PenumbraBTIG Research
Boost Price Target
10/12/2020AbiomedSVB Leerink
Lower Price Target
10/7/2020PenumbraCanaccord Genuity
Reiterated Rating
9/29/2020PenumbraBTIG Research
Initiated Coverage
9/23/2020NovoCureNorthland Securities
Initiated Coverage
9/18/2020NovoCureWells Fargo & Company
Downgrade
9/17/2020NovoCurePiper Sandler
Boost Price Target
9/17/2020NovoCureTruist
Downgrade
9/8/2020PenumbraBank of America
Downgrade
8/7/2020AbiomedMorgan Stanley
Boost Price Target
8/7/2020AbiomedSVB Leerink
Boost Price Target
8/4/2020PenumbraCanaccord Genuity
Boost Price Target
8/4/2020PenumbraWells Fargo & Company
Boost Price Target
8/4/2020PenumbraCitigroup
Boost Price Target
8/3/2020NovoCureSunTrust Banks
Reiterated Rating
7/31/2020NovoCureWedbush
Reiterated Rating
7/13/2020AbiomedOTR Global
Upgrade
5/28/2020AbiomedSVB Leerink
Boost Price Target
5/27/2020AbiomedBTIG Research
Downgrade
5/1/2020AbiomedMorgan Stanley
Boost Price Target
4/27/2020AbiomedSVB Leerink
Downgrade
3/27/2020AbiomedMorgan Stanley
Lower Price Target
3/23/2020AbiomedPiper Sandler
Reiterated Rating
3/23/2020AbiomedStephens
Lower Price Target
2/11/2020AbiomedMorgan Stanley
Downgrade
2/6/2020AbiomedBTIG Research
Initiated Coverage
12/17/2019AbiomedMorgan Stanley
Lower Price Target
11/1/2019AbiomedSVB Leerink
Boost Price Target
(Data available from 10/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.